News for BB Biotech AG (BBAGF)

On March 19, 2025, BB Biotech AG made a significant move by reducing its position in Black Diamond Therapeutics Inc (NASDAQ: BDTX). The firm sold 5,784,292 shar

On March 4, 2025, BB Biotech AG executed a strategic transaction involving Esperion Therapeutics Inc. The firm reduced its holdings by 250,000 shares at a trade

On December 31, 2024, BB Biotech AG made a significant move in the biotechnology sector by acquiring an additional 5,114,399 shares of Macrogenics Inc. This tra

On December 31, 2024, BB Biotech AG executed a notable stock transaction by acquiring 750,000 shares of Esperion Therapeutics Inc. This acquisition was made at

BB Biotech AG, a prominent investment firm, recently executed a significant transaction by acquiring an additional 3,140,000 shares of Black Diamond Therapeutic

On December 31, 2024, BB Biotech AG executed a significant transaction involving Agios Pharmaceuticals Inc. The firm reduced its holdings by 515,642 shares at a

BB Biotech AG, a prominent investment firm, recently expanded its stake in Molecular Templates Inc by acquiring an additional 156,424 shares on November 14, 202

EQS-Ad-hoc: BB Biotech AG / Key word(s): Interim Report BB Biotech AG publishes its interim report 25-Oct-2024 / 07:00 CET/CEST Disclos...

EQS-News: BB Biotech AG / Key word(s): Interim Report BB Biotech: Strategic reallocation of portfolio assets progressing ...

EQS-Ad-hoc: BB BIOTECH AG / Key word: Interim Report BB Biotech AG publishes its interim report 26-Apr-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of...

EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...

EQS-News: BB BIOTECH AG / Key word: AGM/EGM/Dividend Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share ...

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 21.02.2024 / 17:40...

EQS-Ad-hoc: BB BIOTECH AG / Key word: Annual Report/Dividend BB Biotech AG publishes its 2023 annual report 16-Feb-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article...

My portfolio gained 9.94% in 2023 but lagged behind the MSCI World for the second year in a row. Check out promising stocks from my portfolio.

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

SEMI-ANNUAL REPORT 2023 Investors' Information ...